Application of 3D printing in early phase development of pharmaceutical solid dosage forms

Rachel L. Milliken,Thomas Quinten,Sune K. Andersen,Dimitrios A. Lamprou
DOI: https://doi.org/10.1016/j.ijpharm.2024.123902
IF: 6.51
2024-02-15
International Journal of Pharmaceutics
Abstract:Three-dimensional printing (3DP) is an emerging technology, offering the possibility for the development of dose-customized, effective, and safe solid oral dosage forms (SODFs). Although 3DP has great potential, it does come with certain limitations, and the traditional drug manufacturing platforms remain the industry standard. The consensus appears to be that 3DP technology is expected to benefit personalized medicine the most, but that it is unlikely to replace conventional manufacturing for mass production. The 3DP method, on the other hand, could prove well-suited for producing small batches as an adaptive manufacturing technique for enabling adaptive clinical trial design for early clinical studies. The purpose of this review is to discuss recent advancements in 3DP technologies for SODFs and to focus on the applications for SODFs in the early clinical development stages, including a discussion of current regulatory challenges and quality controls.
pharmacology & pharmacy
What problem does this paper attempt to address?